Two Innovative Medicines Initiative neurodegeneration projects are featured in the CORDIS brochure on how the digital revolution is transforming EU-funded brain research. The brochure was published to coincide with IMI’s Stakeholder Forum on the same subject.
The brochure takes a closer look at “AETIONOMY” and its approach to a digital disease classification system; “AETIONOMY systematically captures and represents knowledge on neurodegenerative diseases in a computable format, as a graph model that represents causes and effects and that can be analysed using algorithms.”
The second project that is highlighted is entitled “PRISM“. It is proposing a paradigm shift to develop more adequate and effective treatments for neuropsychiatric disorders. The project moves away from current classification methods to focus on the patients’ underlying neurobiology.
You can read the brochure here.
Are you interested in further achievements and news on projects funded by Europe’s biggest public-private partnership in the life sciences? Have a look at the success stories from the Innovative Medicines Initiative’s research projects: http://bit.ly/IMI-success-stories